<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ca">
	<id>https://rthwiki.iconcologia.net/index.php?action=history&amp;feed=atom&amp;title=BRAF-es</id>
	<title>BRAF-es - Historial de revisió</title>
	<link rel="self" type="application/atom+xml" href="https://rthwiki.iconcologia.net/index.php?action=history&amp;feed=atom&amp;title=BRAF-es"/>
	<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=BRAF-es&amp;action=history"/>
	<updated>2026-05-14T12:12:31Z</updated>
	<subtitle>Historial de revisió per a aquesta pàgina del wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=BRAF-es&amp;diff=1426&amp;oldid=prev</id>
		<title>Lesteban a 10:32, 30 set 2022</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=BRAF-es&amp;diff=1426&amp;oldid=prev"/>
		<updated>2022-09-30T10:32:39Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 10:32, 30 set 2022&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Línia 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Gen que da origen a una proteína que participa en el envío de señales a las células y en la multiplicación celular pudiendo causar cambios que aumenten la multiplicación y la diseminación de las células cancerosas. Se han encontrado formas mutadas del gen BRAF y de su proteína en muchos tipos de cáncer (de colon y recto, carcinoma papilar de tiroides, melanoma, adenocarcinomas del ovario y leucemias, entre otros).&amp;lt;ref&amp;gt;https://www.hopkinsmedicine.org/health/conditions-and-diseases/braf-mutation-and-cancer&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Gen que da origen a una proteína que participa en el envío de señales a las células y en la multiplicación celular pudiendo causar cambios que aumenten la multiplicación y la diseminación de las células cancerosas. Se han encontrado formas mutadas del gen BRAF y de su proteína en muchos tipos de cáncer (de colon y recto, carcinoma papilar de tiroides, melanoma, adenocarcinomas del ovario y leucemias, entre otros).&amp;lt;ref&amp;gt;https://www.hopkinsmedicine.org/health/conditions-and-diseases/braf-mutation-and-cancer&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;A l&#039;&lt;/del&gt;ASEDAT se recoge este marcador para el cáncer de de colon y recto (C18.X, C19.X i C20.X), estómago (C16.X) y melanoma (C44.X y M872-879)&amp;lt;ref&amp;gt;International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/+index.php?option=com_content&amp;amp;view=category&amp;amp;layout=blog&amp;amp;id=100&amp;amp;Itemid=577&amp;lt;/ref&amp;gt; los valores que puede tomar son: Wildtype, mutado, indeterminado o desconocido.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;En &lt;/ins&gt;ASEDAT se recoge este marcador para el cáncer de de colon y recto (C18.X, C19.X i C20.X), estómago (C16.X) y melanoma (C44.X y M872-879)&amp;lt;ref&amp;gt;International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/+index.php?option=com_content&amp;amp;view=category&amp;amp;layout=blog&amp;amp;id=100&amp;amp;Itemid=577&amp;lt;/ref&amp;gt; los valores que puede tomar son: Wildtype, mutado, indeterminado o desconocido.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Lesteban</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=BRAF-es&amp;diff=1425&amp;oldid=prev</id>
		<title>Lesteban a 10:32, 30 set 2022</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=BRAF-es&amp;diff=1425&amp;oldid=prev"/>
		<updated>2022-09-30T10:32:21Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 10:32, 30 set 2022&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Línia 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Gen que da origen a una proteína que participa en el envío de señales a las células y en la multiplicación celular pudiendo causar cambios que aumenten la multiplicación y la diseminación de las células cancerosas. Se han encontrado formas mutadas del gen BRAF y de su proteína en muchos tipos de cáncer (de colon y recto, carcinoma papilar de tiroides, melanoma, adenocarcinomas del ovario y leucemias, entre otros).&amp;lt;ref&amp;gt;https://www.hopkinsmedicine.org/health/conditions-and-diseases/braf-mutation-and-cancer&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Gen que da origen a una proteína que participa en el envío de señales a las células y en la multiplicación celular pudiendo causar cambios que aumenten la multiplicación y la diseminación de las células cancerosas. Se han encontrado formas mutadas del gen BRAF y de su proteína en muchos tipos de cáncer (de colon y recto, carcinoma papilar de tiroides, melanoma, adenocarcinomas del ovario y leucemias, entre otros).&amp;lt;ref&amp;gt;https://www.hopkinsmedicine.org/health/conditions-and-diseases/braf-mutation-and-cancer&amp;lt;/ref&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;En el software &lt;/del&gt;ASEDAT se recoge este marcador para el cáncer de de colon y recto (C18.X, C19.X i C20.X), estómago (C16.X) y melanoma (C44.X y M872-879)&amp;lt;ref&amp;gt;International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/+index.php?option=com_content&amp;amp;view=category&amp;amp;layout=blog&amp;amp;id=100&amp;amp;Itemid=577&amp;lt;/ref&amp;gt; los valores que puede tomar son: Wildtype, mutado, indeterminado o desconocido.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;A l&#039;&lt;/ins&gt;ASEDAT se recoge este marcador para el cáncer de de colon y recto (C18.X, C19.X i C20.X), estómago (C16.X) y melanoma (C44.X y M872-879)&amp;lt;ref&amp;gt;International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/+index.php?option=com_content&amp;amp;view=category&amp;amp;layout=blog&amp;amp;id=100&amp;amp;Itemid=577&amp;lt;/ref&amp;gt; los valores que puede tomar son: Wildtype, mutado, indeterminado o desconocido.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Lesteban</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=BRAF-es&amp;diff=1023&amp;oldid=prev</id>
		<title>Lesteban a 07:58, 22 juny 2022</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=BRAF-es&amp;diff=1023&amp;oldid=prev"/>
		<updated>2022-06-22T07:58:55Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ca&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Versió més antiga&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revisió del 07:58, 22 juny 2022&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l2&quot;&gt;Línia 2:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Línia 2:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;En el software ASEDAT se recoge este marcador para el cáncer de de colon y recto (C18.X, C19.X i C20.X), estómago (C16.X) y melanoma (C44.X y M872-879)&amp;lt;ref&amp;gt;International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/+index.php?option=com_content&amp;amp;view=category&amp;amp;layout=blog&amp;amp;id=100&amp;amp;Itemid=577&amp;lt;/ref&amp;gt; los valores que puede tomar son: Wildtype, mutado, indeterminado o desconocido.&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;En el software ASEDAT se recoge este marcador para el cáncer de de colon y recto (C18.X, C19.X i C20.X), estómago (C16.X) y melanoma (C44.X y M872-879)&amp;lt;ref&amp;gt;International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/+index.php?option=com_content&amp;amp;view=category&amp;amp;layout=blog&amp;amp;id=100&amp;amp;Itemid=577&amp;lt;/ref&amp;gt; los valores que puede tomar son: Wildtype, mutado, indeterminado o desconocido.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Referencias bibliográficas&amp;#039;&amp;#039;&amp;#039;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Referencias bibliográficas&amp;#039;&amp;#039;&amp;#039;&amp;lt;references /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Categoria:Variables del registro]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Lesteban</name></author>
	</entry>
	<entry>
		<id>https://rthwiki.iconcologia.net/index.php?title=BRAF-es&amp;diff=1022&amp;oldid=prev</id>
		<title>Lesteban: BRAF-es</title>
		<link rel="alternate" type="text/html" href="https://rthwiki.iconcologia.net/index.php?title=BRAF-es&amp;diff=1022&amp;oldid=prev"/>
		<updated>2022-06-22T07:58:38Z</updated>

		<summary type="html">&lt;p&gt;BRAF-es&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Pàgina nova&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Gen que da origen a una proteína que participa en el envío de señales a las células y en la multiplicación celular pudiendo causar cambios que aumenten la multiplicación y la diseminación de las células cancerosas. Se han encontrado formas mutadas del gen BRAF y de su proteína en muchos tipos de cáncer (de colon y recto, carcinoma papilar de tiroides, melanoma, adenocarcinomas del ovario y leucemias, entre otros).&amp;lt;ref&amp;gt;https://www.hopkinsmedicine.org/health/conditions-and-diseases/braf-mutation-and-cancer&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
En el software ASEDAT se recoge este marcador para el cáncer de de colon y recto (C18.X, C19.X i C20.X), estómago (C16.X) y melanoma (C44.X y M872-879)&amp;lt;ref&amp;gt;International Classification of Diseases for Oncology (ICD-O) - 3rd edition, 2nd revision. http://www.iacr.com.fr/+index.php?option=com_content&amp;amp;view=category&amp;amp;layout=blog&amp;amp;id=100&amp;amp;Itemid=577&amp;lt;/ref&amp;gt; los valores que puede tomar son: Wildtype, mutado, indeterminado o desconocido.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Referencias bibliográficas&amp;#039;&amp;#039;&amp;#039;&amp;lt;references /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Lesteban</name></author>
	</entry>
</feed>